Lesions of the optic nerve

Handbook of Clinical Neurology

Volumn 102, Issue , 2011, Pages 159-184

  Atkins, Edward J ^a   Newman, Nancy J ^a   Biousse, Valerie ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 79956148540     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52903-9.00012-1     Document Type: Book

References (59)

1. Amati-Bonneau P., Valentino M.L., Reynier P., et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008, 131:338-351.
2. Atkins E.J., Biousse V., Newman N.J. The natural history of optic neuritis. Rev Neurol Dis 2006, 3:45-55.
3. Atkins E.J., Newman N.J., Biousse V. Post-traumatic visual loss. Rev Neurol Dis 2008, 5:73-81.
4. Atkins E.J., Newman N.J., Bruce B.B., et al. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 2010, 55:47-63.
5. Ball A.K., Clarke C.E. Idiopathic intracranial hypertension. Lancet Neurol 2006, 5:433-442.
6. Bataller L., Dalmau J. Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol 2004, 17:3-8.
7. Beck R.W., Cleary P.A., Anderson M.M., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992, 326:581-588.
8. Beck R.W., Cleary P.A., Trobe J.D., et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993, 329:1764-1769.
9. Bhatti M.T. Orbital syndromes. Semin Neurol 2007, 27:269-287.
10. Biousse V., Newman N.J. Neuro-Ophthalmology Illustrated 2009, Thieme, New York, pp. 196, 254.
11. Bruce B.B., Kedar S., Van Stavern G.P., et al. Idiopathic intracranial hypertension in men. Neurology 2009, 72:304-309.
12. CHAMPIONS Study Group IM interferonβ-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006, 66:678-684.
13. CHAMPS Study Group Interferon β-1a for optic neuritis patients at high-risk for multiple sclerosis. Am J Ophthalmol 2001, 132:463-471.
14. Comi C., Filippi M., Barkhof F., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001, 357:1576-1582.
15. Coyle P.K. Early treatment of multiple sclerosis to prevent neurologic damage. Neurology 2008, 71:S3-S7.
16. Danesh-Meyer H.V. Radiation-induced optic neuropathy. J Clin Neurosci 2008, 15:95-100.
17. Danesh-Meyer H.V., Papchenko T., Savino P.J., et al. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci 2008, 49:1879-1885.
18. Eiberg H., Kjer B., Kjer P., et al. Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis. Hum Mol Genet 1994, 3:977-980.
19. Fadil H., Kelley R.E., Gonzalez-Toledo E. Differential diagnosis of multiple sclerosis. Int Rev Neurobiol 2007, 79:393-422.
20. Fraser J.A., Weyand C.M., Newman N.J., et al. The treatment of giant cell arteritis. Rev Neurol Dis 2008, 5:140-152.
21. Friedman D.I., Jacobson D.M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002, 59:1492-1495.
22. Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 1982, 45:13-18.
23. Frohman E.M., Fujimoto J.G., Frohman T.C., et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008, 4:664-675.
24. Fry C.L., Carter J.E., Kanter M.C., et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993, 24:539-542.
25. Garg S., Jampol L.M. Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol 2005, 50:3-13.
26. Giovannoni G. To test or not to test: NMO-IgG and optic neuritis. Neurology 2008, 70:2192-2193.
27. Glisson C.C., Galetta S.L. Nonconventional optic nerve imaging in multiple sclerosis. Neuroimaging Clin North Am 2009, 19:71-79.
28. Hayreh S.S. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye 2004, 18:1188-1206.
29. Hayreh S.S., Zimmerman M.B. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmology 2007, 245:1107-1121.
30. Hayreh S.S., Joos K.M., Podhajsky P.A., et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994, 118:766-780.
31. Hayreh S.S., Jonas J.B., Zimmerman M.B. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology 2007, 114:804-809.
32. Ischemic Optic Neuropathy Decompression Trial Research Group Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995, 273:625-632.
33. Kappos L., Freedman M.S., Polman C.H., et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007, 370:389-397.
34. Kaufman D.I., Trobe J.D., Eggenberger E.R., et al. Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Neurology 2000, 54:2039-2044.
35. Lee A.G., Newman N.J. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2005, 140:707-708.
36. Levin L.A., Beck R.W., Joseph M.P., et al. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 1999, 106:1268-1277.
37. Luneau K., Newman N.J., Biousse V. Ischemic optic neuropathies. Neurologist 2008, 14:341-354.
38. Melson M.R., Weyand C.M., Newman N.J., et al. The diagnosis of giant cell arteritis. Rev Neurol Dis 2007, 4:128-142.
39. Mikelberg F.S., Drance S.M., Schulzer M., et al. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology 1989, 96:1325-1328.
40. Murphy M.A., Murphy J.F. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthalmol 2005, 25:232-236.
41. Newman N.J. Optic neuropathy. Neurology 1996, 46:315-322.
42. Newman N.J. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol 2008, 145:604-610.
43. Newman N.J., Scherer R., Langenberg P., et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002, 134:317-328.
44. Optic Neuritis Study Group Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol 2004, 137:77-83.
45. Optic Neuritis Study Group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008, 65:727-732.
46. Preechawat P., Beau B.B., Newman N.J., et al. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol 2007, 144:653-660.
47. Purvin V.A., Chioran G. Recurrent neuroretinitis. Arch Ophthalmol 1994, 112:365-371.
48. Reynier P., Amati-Bonneau P., Verny C., et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet 2004, 41:e110.
49. Rucker J.C., Hamilton S.R., Bardenstein D., et al. Linezolid-associated toxic optic neuropathy. Neurology 2006, 66:595-598.
50. Sadda S.R., Nee M., Miller N.R., et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 2001, 132:743-750.
51. Sandbach J.M., Newman N.J. Retinal masqueraders of optic nerve disease. Ophthalmol Clin North Am 2001, 14:41-59.
52. Steinsapir K.D. Treatment of traumatic optic neuropathy with high-dose corticosteroid. J Neuroophthalmol 2006, 26:65-67.
53. Thambisetty M., Lavin P.J., Newman N.J., et al. Fulminant idiopathic intracranial hypertension. Neurology 2007, 68:229-232.
54. Tintoré M., Rovira A., Río J., et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology 2008, 70:1079-1083.
55. Trobe J.D., Glaser J.S., Cassady J.C. Optic atrophy. Differential diagnosis by fundus observation alone. Arch Ophthalmol 1980, 98:1040-1045.
56. van Overbeeke J., Sekhar L. Microanatomy of the blood supply to the optic nerve. Orbit 2003, 22:81-88.
57. Van Stavern G.P., Newman N.J. Optic neuropathies. An overview. Ophthalmol Clin North Am 2001, 14:61-71.
58. Volpe N.J. The optic neuritis treatment trial. Arch Ophthalmol 2008, 126:996-999.
59. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.